ATA337185A - Verfahren zur herstellung neuer flavolignanderivate - Google Patents

Verfahren zur herstellung neuer flavolignanderivate

Info

Publication number
ATA337185A
ATA337185A AT3371/85A AT337185A ATA337185A AT A337185 A ATA337185 A AT A337185A AT 3371/85 A AT3371/85 A AT 3371/85A AT 337185 A AT337185 A AT 337185A AT A337185 A ATA337185 A AT A337185A
Authority
AT
Austria
Prior art keywords
flavole
derivatives
producing new
producing
new
Prior art date
Application number
AT3371/85A
Other languages
English (en)
Other versions
AT393268B (de
Inventor
Reinhard Dr Braatz
Klaus Dr Goerler
Guenter Dr Halbach
Hartwig Dr Soicke
Karlheinz Ddr Schmidt
Original Assignee
Madaus & Co Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Madaus & Co Dr filed Critical Madaus & Co Dr
Publication of ATA337185A publication Critical patent/ATA337185A/de
Application granted granted Critical
Publication of AT393268B publication Critical patent/AT393268B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Silicon Compounds (AREA)
AT3371/85A 1984-11-22 1985-11-19 Verfahren zur herstellung neuer flavolignanderivate AT393268B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843442639 DE3442639A1 (de) 1984-11-22 1984-11-22 Flavolignanderivate, verfahren zu deren herstellung und arzneimittel, die diese verbindungen enthalten

Publications (2)

Publication Number Publication Date
ATA337185A true ATA337185A (de) 1991-02-15
AT393268B AT393268B (de) 1991-09-25

Family

ID=6250903

Family Applications (1)

Application Number Title Priority Date Filing Date
AT3371/85A AT393268B (de) 1984-11-22 1985-11-19 Verfahren zur herstellung neuer flavolignanderivate

Country Status (29)

Country Link
JP (1) JPS61143377A (de)
KR (1) KR870001020B1 (de)
AR (1) AR240931A1 (de)
AT (1) AT393268B (de)
BE (1) BE903693A (de)
CA (1) CA1337124C (de)
CH (1) CH659473A5 (de)
CS (1) CS273610B2 (de)
DD (1) DD259191A1 (de)
DE (1) DE3442639A1 (de)
DK (1) DK164865C (de)
EG (1) EG19424A (de)
ES (1) ES8609311A1 (de)
FI (1) FI84064C (de)
FR (1) FR2573427B1 (de)
GB (1) GB2167414B (de)
HU (1) HU195503B (de)
IE (1) IE58791B1 (de)
IT (1) IT1190426B (de)
LU (1) LU86163A1 (de)
MX (1) MX168415B (de)
NL (1) NL192387C (de)
NO (1) NO160205C (de)
PL (1) PL146890B1 (de)
PT (1) PT81532B (de)
SE (1) SE465676B (de)
SU (1) SU1436875A3 (de)
YU (1) YU43689B (de)
ZA (1) ZA858951B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8716918D0 (en) * 1987-07-17 1987-08-26 Inverni Della Beffa Spa Soluble derivatives of silybin
US5262439A (en) * 1992-04-30 1993-11-16 The Regents Of The University Of California Soluble analogs of probucol
CA2601028C (en) * 2005-03-11 2014-05-27 Howard Florey Institute Of Experimental Physiology And Medecine Flavonoid compounds and uses thereof
CN102300570B (zh) * 2007-11-15 2015-01-14 马道斯有限责任公司 用于治疗肝炎的水飞蓟宾组分
RU2482844C2 (ru) * 2007-11-15 2013-05-27 Мадаус Гмбх Силибининовый компонент для лечения гепатита
PT2430017T (pt) 2009-05-14 2016-10-12 Madaus Gmbh Método para a preparação de silibinina amorfa
CA2877329C (en) 2012-07-05 2020-01-07 Nutramax Laboratories, Inc. Compositions comprising sulforaphane or a sulforaphane precursor and magnesium
CN103172622B (zh) * 2013-02-22 2015-11-04 西安安健药业有限公司 水飞蓟宾二偏琥珀酸酯的活性异构体
CN103193768B (zh) * 2013-02-22 2016-03-30 西安安健药业有限公司 治疗肝病的水飞蓟宾二偏琥珀酸酯异构体
CN103113359B (zh) * 2013-02-22 2016-01-06 西安安健药业有限公司 水飞蓟宾二偏琥珀酸酯及其药用盐

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1963318A1 (de) * 1969-12-17 1971-06-24 Schwabe Willmar Gmbh & Co Silybinhalbester der Bernsteinsaeure und der Phthalsaeure,ihre Salze mit pharmakologisch vertraglichen Basen,Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneipraeparaten

Also Published As

Publication number Publication date
HU195503B (en) 1988-05-30
FR2573427A1 (fr) 1986-05-23
NL8503171A (nl) 1986-06-16
CH659473A5 (de) 1987-01-30
BE903693A (fr) 1986-05-22
EG19424A (en) 1995-02-28
CS837885A2 (en) 1990-08-14
SE8505487D0 (sv) 1985-11-20
YU178685A (en) 1988-02-29
DK164865B (da) 1992-08-31
FI854535A0 (fi) 1985-11-18
CA1337124C (en) 1995-09-26
ES8609311A1 (es) 1986-09-01
ES549116A0 (es) 1986-09-01
DE3442639A1 (de) 1986-05-22
IE852808L (en) 1986-05-22
CS273610B2 (en) 1991-03-12
DK164865C (da) 1993-01-18
AR240931A1 (es) 1991-03-27
NO160205C (no) 1989-03-22
SU1436875A3 (ru) 1988-11-07
GB2167414A (en) 1986-05-29
PL146890B1 (en) 1989-03-31
SE465676B (sv) 1991-10-14
KR860004056A (ko) 1986-06-16
DK537785A (da) 1986-05-23
YU43689B (en) 1989-10-31
DK537785D0 (da) 1985-11-21
LU86163A1 (de) 1986-03-24
JPS61143377A (ja) 1986-07-01
NO160205B (no) 1988-12-12
GB8528226D0 (en) 1985-12-18
NL192387B (nl) 1997-03-03
DE3442639C2 (de) 1989-08-10
PL256374A1 (en) 1986-12-02
ZA858951B (en) 1986-08-27
FR2573427B1 (fr) 1989-03-10
AT393268B (de) 1991-09-25
JPH0432073B2 (de) 1992-05-28
KR870001020B1 (ko) 1987-05-23
HUT40114A (en) 1986-11-28
GB2167414B (en) 1989-01-11
FI84064C (fi) 1991-10-10
SE8505487L (sv) 1986-05-23
MX168415B (es) 1993-05-24
NL192387C (nl) 1997-07-04
FI854535A7 (fi) 1986-05-23
AR240931A2 (es) 1991-03-27
PT81532A (de) 1985-12-01
PT81532B (pt) 1987-11-11
DD259191A1 (de) 1988-08-17
IE58791B1 (en) 1993-11-17
IT1190426B (it) 1988-02-16
IT8522932A0 (it) 1985-11-21
NO854655L (no) 1986-05-23
FI84064B (fi) 1991-06-28

Similar Documents

Publication Publication Date Title
AT373599B (de) Verfahren zur herstellung neuer rifamycinderivate
AT389302B (de) Verfahren zur herstellung neuer 3-benzylidencamphersulfonamidderivate
ATA71183A (de) Verfahren zur herstellung neuer 3-keto-delta 4,9,19-norsteroid-derivate
ATA115486A (de) Verfahren zur herstellung neuer antibiotischer makrolite
ATA376184A (de) Verfahren zur herstellung neuer polysubstituierter naphthalinderivate
AT382381B (de) Verfahren zur herstellung neuer grenzfl|chenaktiver kohlenhydrat-derivate
AT386208B (de) Verfahren zur herstellung neuer carbapenemzwischenverbindungen
ATA165685A (de) Verfahren zur herstellung neuer 1,3-oxazolidin-2- derivate
ATA337185A (de) Verfahren zur herstellung neuer flavolignanderivate
ATA233086A (de) Verfahren zur herstellung neuer peptidantibiotika
ATA124285A (de) Verfahren zur herstellung neuer iminothiazolidinderivate
ATA335685A (de) Verfahren zur herstellung neuer thienopyridinderivate
ATA444982A (de) Verfahren zur herstellung neuer bisindolalkaloidderivate
ATA172385A (de) Verfahren zur herstellung neuer naphthoxazine
ATA371584A (de) Verfahren zur herstellung neuer cephalosporanderivate
AT376217B (de) Verfahren zur herstellung neuer 3-chlorchinolinderivate
ATA305785A (de) Verfahren zur herstellung neuer 4h-dioxino-(4,5-c)-pyridinderivate
ATA257386A (de) Verfahren zur herstellung neuer brenzcatechinderivate
ATA215987A (de) Verfahren zur herstellung neuer chinazolinonverbindungen
ATA143885A (de) Verfahren zur herstellung neuer chinolinderivate
AT388558B (de) Verfahren zur herstellung neuer pyranoderivate
AT383118B (de) Verfahren zur herstellung neuer azetidinonderivate
ATA86285A (de) Verfahren zur herstellung neuer thiazolderivate
ATA193885A (de) Verfahren zur herstellung neuer 3-amino-3-desoxy- d-glucosederivate
ATA129883A (de) Verfahren zur herstellung neuer pyrogallolaether-derivate

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee